Mar 5, 2025 | Press Releases
FREMONT, Calif. – Tivic Health® Systems, Inc. (Nasdaq: TIVC) (“Tivic Health” or the “Company), a diversified therapeutics company, announced today that its Board of Directors has declared a 1-for-17 reverse stock split of the...
Mar 3, 2025 | Press Releases
– Patent based on state-of-the-art science of vagus nerve stimulation approach shows greater effect from personalization of treatment – FREMONT, Calif. – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company harnessing...
Feb 24, 2025 | Press Releases
Handley Joins as President of Tivic Biopharma and Chief Operating Officer of Tivic Health Following Its Licensing of Strategic Biopharma Assets From Statera Biopharma FREMONT, Calif. – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics...
Feb 12, 2025 | Press Releases
Broad licensing agreement accelerates Tivic’s transformation into a diversified therapeutics company, adds late-stage immunotherapeutic to clinical pipeline. Potential for FDA approval within 24 months. FREMONT, Calif. – Tivic Health Systems, Inc.,...
Dec 23, 2024 | Press Releases
Provides updates on vagus nerve stimulation (VNS) program and expectations for 2025 FREMONT, Calif. – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, today released its annual CEO...
Nov 14, 2024 | Press Releases
Pre-recorded Conference Call to Follow at 1:30 p.m. PDT/4:30 p.m EDT FREMONT, Calif. – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-months...
